AUSTIN WHEELWRIGHT: Open Payments
NPI 1225764962 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 26 payments from 7 companies in 2025. Trend: 2023 $605 · 2024 $653 · 2025 $495
Food & beverage: $485Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $268 |
| GENZYME CORPORATION | 3 | $65 |
| LEO Pharma Inc. | 2 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $30 |
| Organon LLC | 1 | $15 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, ADBRY, Zoryve, OTEZLA, Odomzo, VTAMA.
Industry payments across ID — which companies pay providers there.
